This risk is higher when Ondansetron is used in combination with other medications that also increase serotonin levels, such as selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs)
Important notice: Compounded glutathione is not FDA-approved
[1] [2] Patients with these conditions should not receive these medications, and alternative treatments for diabetes or weight management should be considered
Available from: Beaudart C, McCloskey E, Bruyre O, Cesari M, Rolland Y, Rizzoli R, et al
V prescribes BPC-157 for patients with leaky gut syndrome, inflammatory bowel conditions, gastric ulceration, and intestinal permeability issues
Is microdosing semaglutide approved by the FDA